|Articles|June 9, 2004
FDA approves ISTA product, asked to evaluate another
On May 6 the FDA approved ISTA Pharmaceutical's new drug application (NDA) for lyophilized, ovine hyaluronidase for injection (Vitrase) for use as a spreading agent to facilitate the dispersion and absorption of other drugs.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Transformative advances in vision research: It’s the science
2
Pediatric and strabismus care: Evolving tools, emerging therapies
3
What if? Ophthalmology without OCT – Part 5
4
LASIK and beyond: Navigating the changing landscape of refractive surgery
5













































.png)


